Tilray Brands, Inc. (TLRY) Rises as Broader Market Declines: Key Points to Consider

Tilray Brands Outperforms Market Despite Sector Challenges

During the most recent trading day, Tilray Brands (NASDAQ: TLRY) ended the session at $7.99, reflecting a 2.04% increase from the prior close. This positive movement contrasted with the S&P 500, which declined by 0.54%. In comparison, the Dow Jones inched up by 0.03%, while the Nasdaq Composite, heavily weighted toward technology stocks, dropped by 1.18%.

Over the past month, Tilray Brands' stock price slipped by 0.25%. This performance was better than the Medical sector's 0.62% decline but lagged behind the S&P 500's 0.58% gain during the same period.

Upcoming Earnings and Analyst Expectations

Investors are closely watching Tilray Brands' upcoming earnings report. Analysts anticipate the company will report a loss of $0.14 per share, which would represent an 86% improvement compared to the same quarter last year. Revenue is projected to reach $205.93 million, an increase of 10.85% year-over-year.

For the full fiscal year, consensus estimates suggest Tilray Brands will post a loss of $0.56 per share and generate $871.99 million in revenue. These figures indicate a 660% decrease in earnings and a 6.17% rise in revenue compared to the previous year.

Analyst Revisions and Stock Outlook

It's important for investors to monitor any recent changes in analyst forecasts for Tilray Brands. Such revisions often reflect the latest business trends and can signal shifts in analysts' perspectives on the company's prospects. Positive estimate changes typically suggest growing confidence in the company's performance and profitability.

Research shows that these forecast adjustments are often linked to short-term stock price movements. The Zacks Rank system was developed to leverage this relationship, providing investors with a straightforward rating based on estimate changes.

Understanding the Zacks Rank System

The Zacks Rank ranges from #1 (Strong Buy) to #5 (Strong Sell) and has a strong track record, with #1 ranked stocks delivering an average annual return of 25% since 1988. Over the past month, the consensus earnings estimate for Tilray Brands has remained steady, and the company currently holds a Zacks Rank of #3 (Hold).

Industry Overview

Tilray Brands operates within the Medical - Products industry, which is part of the broader Medical sector. Currently, this industry is ranked 145th by Zacks, placing it in the bottom 41% among more than 250 industries tracked.

The Zacks Industry Rank evaluates the strength of each industry group by averaging the Zacks Ranks of the individual stocks within them. Historically, industries in the top half of the rankings have outperformed those in the lower half by a two-to-one margin.

For ongoing updates and analysis on these and other market-moving factors, investors can utilize resources throughout upcoming trading sessions.

New: Zacks Top 10 Stocks for 2026

There’s still time to get early access to Zacks’ top 10 stock picks for 2026. Curated by Director of Research Sheraz Mian, this portfolio has delivered impressive and consistent results.

Since its launch in 2012 through November 2025, the Zacks Top 10 Stocks have soared by 2,530.8%, outpacing the S&P 500’s 570.3% gain by more than fourfold.

Sheraz Mian has reviewed 4,400 companies covered by the Zacks Rank and selected the ten best stocks to buy and hold for 2026. Be among the first to discover these high-potential picks.

Additional Resources